Applied DNA Sciences, Inc. Share Price BOERSE MUENCHEN

Equities

UDJ

US03815U4094

Medical Equipment, Supplies & Distribution

Real-time BOERSE MUENCHEN 14:43:34 27/06/2024 BST 5-day change 1st Jan Change
0.43 EUR +8.59% Intraday chart for Applied DNA Sciences, Inc. -1.00% -96.64%

Financials

Sales 2024 * 4.5M 4.2M 355M Sales 2025 * 6.76M 6.31M 534M Capitalization 4.16M 3.88M 329M
Net income 2024 * -12M -11.19M -948M Net income 2025 * -13M -12.13M -1.03B EV / Sales 2024 * 0.93 x
Net cash position 2024 * - 0 0 Net cash position 2025 * - 0 0 EV / Sales 2025 * 0.62 x
P/E ratio 2024 *
-0.08 x
P/E ratio 2025 *
-0.43 x
Employees -
Yield 2024 *
-
Yield 2025 *
-
Free-Float 96.49%
More Fundamentals * Assessed data
Dynamic Chart
1 week-1.00%
Current month-22.35%
1 month-78.24%
3 months-95.33%
6 months-96.39%
Current year-96.64%
More quotes
1 week
0.33
Extreme 0.33
0.46
1 month
0.33
Extreme 0.33
1.82
3 years
0.33
Extreme 0.33
145.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 71 27/09/05
Director of Finance/CFO 47 30/04/13
Chief Tech/Sci/R&D Officer - -
Members of the board TitleAgeSince
Director/Board Member 74 16/03/06
Director/Board Member 87 06/10/16
Chief Executive Officer 71 27/09/05
More insiders
Date Price Change
27/06/24 0.43 +8.59%
26/06/24 0.396 -1.00%
25/06/24 0.4 0.00%
24/06/24 0.4 -3.85%
21/06/24 0.416 +4.00%

Real-time BOERSE MUENCHEN, June 27, 2024 at 02:43 pm

More quotes
Applied DNA Sciences, Inc. is a biotechnology company that develops, and markets deoxyribonucleic acid (DNA) based technology solutions. The Company is utilizing its LinearDNA large-scale polymerase chain reaction (PCR) based manufacturing platform. The Company’s proprietary platform produces large quantities of DNA for use in the nucleic acid-based in vitro diagnostics and preclinical nucleic-acid based drug development and manufacturing markets and for supply chain security, anti-counterfeiting and anti-theft technology purposes. It also develops PCR-based molecular in vitro diagnostics for covid-19. In addition, under its wholly owned subsidiary, Applied DNA Clinical Labs, LLC, the Company is offering a high-throughput turnkey solution for population-scale Covid-19 testing marketed as safeCircle. safeCircle utilizes the Company’s Covid-19 Diagnostic Tests and is designed to look for infection within defined populations or communities utilizing high throughput testing methodologies.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
0.4075 USD
Average target price
30 USD
Spread / Average Target
+7,261.96%
Consensus